Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Intravenous (IV) Ibuprofen Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global intravenous (IV) ibuprofen market size reached US$ 5.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.48 Billion by 2027, exhibiting a growth rate (CAGR) of 8.10% during 2022-2027.

Ibuprofen belongs to the nonsteroidal anti-inflammatory drug (NSAID) class used to treat inflammation, pain, and fever. It inhibits cyclooxygenase COZ-1 and COX-2 enzymes that are required for the synthesis of prostaglandins (PG). Intravenous (IV) ibuprofen is used alone or with other medicines to relieve mild to severe discomfort. It is injected directly into the vein to block the body's production of certain natural substances that cause inflammation. It helps to reduce narcotic analgesic requirements and lower pain levels with an excellent safety profile. IV ibuprofen also aids in improving pain control and reducing the usage of opioid drugs in orthopedic and abdominal surgeries and fever.

Intravenous (IV) Ibuprofen Market Trends:

The steadily rising geriatric population and the increasing prevalence of arthritis, cardiovascular diseases (CVDs), and cancer across the globe are creating a positive outlook for the market. In line with this, the widespread product adoption to manage and treat inflammatory diseases, rheumatoid disorders, mild to moderate pain, fever, dysmenorrhea, and osteoarthritis is favoring the market growth. Moreover, hectic working schedules and unhealthy lifestyles, along with a consequent decline in physical activity and proper nutrition, have led to a rise in the incidences of chronic diseases, which is acting as another growth-inducing factor. Apart from this, the increasing product utilization to treat mild fever, dental pain, gastrointestinal pain, and ductus arteriosus in pediatrics is providing an impetus to the market growth. Moreover, IV ibuprofen is employed to relieve muscle or rheumatic pain, backache, neuralgia, sprains, strains, sports injuries, and musculoskeletal diseases, which is facilitating the market growth. Furthermore, the increasing demand for IV ibuprofen in orthopedic patients post knee or hip replacement surgeries to reduce pain and morphine use is positively influencing the market growth. Other factors, including significant improvements in the healthcare infrastructure, growing health consciousness among individuals, and the rising expenditure capacities of consumers, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global intravenous (IV) ibuprofen market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product dose, indication and age group.

Breakup by Product Dose:

  • 100 Mg Dose
  • 200 Mg Dose
  • 400 Mg Dose
  • 800 Mg Dose
     

Breakup by Indication:

  • Pain/Inflammatory
  • Fever
     

Breakup by Age Group:

  • Pediatrics
  • Adults
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Recordati Rare Diseases Inc., VALMOR Laboratories CA and Xgen Pharmaceuticals Djb Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product Dose, Indication, Age Group, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Recordati Rare Diseases Inc., VALMOR Laboratories CA and Xgen Pharmaceuticals Djb Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global intravenous (IV) ibuprofen market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global intravenous (IV) ibuprofen market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product dose?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the age group?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global intravenous (IV) ibuprofen market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Intravenous (IV) Ibuprofen Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product Dose
    6.1    100 Mg Dose
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    200 Mg Dose
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    400 Mg Dose
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    800 Mg Dose
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Indication
    7.1    Pain/Inflammatory
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Fever
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Age Group
    8.1    Pediatrics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Adults
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Cumberland Pharmaceuticals Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Hyloris Pharmaceuticals SA
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
        14.3.3    Recordati Rare Diseases Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    VALMOR Laboratories CA
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Xgen Pharmaceuticals Djb Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio

List of Figures

Figure 1: Global: Intravenous Ibuprofen Market: Major Drivers and Challenges
Figure 2: Global: Intravenous Ibuprofen Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Intravenous Ibuprofen Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Intravenous Ibuprofen Market: Breakup by Product Dose (in %), 2021
Figure 5: Global: Intravenous Ibuprofen Market: Breakup by Indication (in %), 2021
Figure 6: Global: Intravenous Ibuprofen Market: Breakup by Age Group (in %), 2021
Figure 7: Global: Intravenous Ibuprofen Market: Breakup by Region (in %), 2021
Figure 8: Global: Intravenous Ibuprofen (100 Mg Dose) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Intravenous Ibuprofen (100 Mg Dose) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Intravenous Ibuprofen (200 Mg Dose) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Intravenous Ibuprofen (200 Mg Dose) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Intravenous Ibuprofen (400 Mg Dose) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Intravenous Ibuprofen (400 Mg Dose) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Intravenous Ibuprofen (800 Mg Dose) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Intravenous Ibuprofen (800 Mg Dose) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Intravenous Ibuprofen (Fever) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Intravenous Ibuprofen (Fever) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Intravenous Ibuprofen (Pediatrics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Intravenous Ibuprofen (Pediatrics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Intravenous Ibuprofen (Adults) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Intravenous Ibuprofen (Adults) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: North America: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: North America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: United States: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: United States: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Canada: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Canada: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Asia-Pacific: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Asia-Pacific: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: China: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: China: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Japan: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Japan: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: India: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: India: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: South Korea: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: South Korea: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Australia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Australia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Indonesia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Indonesia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Europe: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Europe: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Germany: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Germany: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: France: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: France: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: United Kingdom: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: United Kingdom: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Italy: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Italy: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Spain: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Spain: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Russia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Russia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Latin America: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Latin America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Brazil: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Brazil: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Mexico: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Mexico: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Middle East and Africa: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Middle East and Africa: Intravenous Ibuprofen Market: Breakup by Country (in %), 2021
Figure 72: Middle East and Africa: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Global: Intravenous Ibuprofen Industry: SWOT Analysis
Figure 74: Global: Intravenous Ibuprofen Industry: Value Chain Analysis
Figure 75: Global: Intravenous Ibuprofen Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Intravenous Ibuprofen Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Intravenous Ibuprofen Market Forecast: Breakup by Product Dose (in Million US$), 2022-2027
Table 3: Global: Intravenous Ibuprofen Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 4: Global: Intravenous Ibuprofen Market Forecast: Breakup by Age Group (in Million US$), 2022-2027
Table 5: Global: Intravenous Ibuprofen Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Intravenous Ibuprofen Market: Competitive Structure
Table 7: Global: Intravenous Ibuprofen Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4